non-Hodgkin's lymphoma
From: The Columbia Encyclopedia, Sixth Edition
|
Date: 2008
non-Hodgkin's lymphoma any cancer of the lymphoid tissue (see lymphatic system ) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present. There are about 10 different types of non-Hodgkin's lymphomas, some slower- or faster-growing than others. Non-Hodgkin's lymphoma can affect children as well as adults. In most cases the cause is unknown, but an increased incidence has been observed in people who have been exposed to Agent Orange , and some forms of the disease are frequently seen in people with AIDS , many of these in association with latent Epstein-Barr virus infection.
Symptoms
The first symptom of non-Hodgkin's lymphoma is often a painless swelling of a lymph node in the neck, the groin, or under the arm. Other symptoms include fever, night sweats, itching, and unexplained weight loss. Diagnosis is made by laboratory study of tissue obtained by taking a biopsy of the suspicious lymph node or nodes.
Treatment
Treatment depends on how far the disease has progressed. It may include external-beam radiation therapy, chemotherapy, or biological therapy (boosting the body's immune response to the disease). Rituxan, a genetically engineered drug involving monoclonal antibodies , has been approved for use against some low-grade (slow-growing) non-Hodgkin's lymphoma.
Bone marrow transplantation is also sometimes used. In this technique, bone marrow (blood cell-producing tissue inside bone) is taken from the patient and treated to kill any cancer cells. The patient is then given very high dose chemotherapy designed to destroy the cancer; it also destroys the remaining bone marrow. After chemotherapy, the stored marrow is reinserted into the patient. In children, chemotherapy is the most common treatment.
Bibliography
See publications of the National Cancer Institute and the American Cancer Society.
Author not available, LYMPHOMA, NON-HODGKIN'S.,
The Columbia Encyclopedia, Sixth Edition 2008
The Columbia Encyclopedia, Sixth Edition. Copyright 2008 Columbia University Press
For permission to reuse this article, contact Copyright Clearance Center.
Related articles from HighBeam Research:
|
^sup 90^Y-Ibritumomab tiuxetan in the treatment of relapsed or refractory B-cell non-Hodgkin's lymphoma*
Journal of Nuclear Medicine Technology; 6/1/2003; Fink-Bennett, Darlene M; Thomas, Kathy; 5089 words;
Objective: Non-Hodgkin's lymphoma (NHL) is the most frequently ... therapy protocol. Key Words: non-Hodgkin's lymphoma; radioimmunotherapy; ibritumomab ... for the treatment of B-cell non-Hodgkin's lymphoma (NHL). Ibritumomab tiuxetan ...
|
|
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: From clinical trails to clinical practice
The Journal of Nuclear Medicine; 11/1/2002; Juweid, Malik E; 20990 words;
... treatment modality for B-- cell non-Hodgkin's lymphoma (NHL). Recent clinical trials ... patients. Key Words: B-cell non-Hodgkin's lymphoma; radioimmunotherapy; monoclonal ... directed against B-cell non-Hodgkin's lymphoma (NHL); rituximab is a ...
|
|
Tositumomab and ^sup 131^I Therapy in Non-Hodgkin's Lymphoma
The Journal of Nuclear Medicine; 1/1/2005; Wahl, Richard L; 10397 words;
... for patients with CD20+ follicular non-Hodgkin's lymphoma (NHL). Currently, it is approved ... I-tositumomab therapy; radioimmunotherapy; non-Hodgkin's lymphoma J Nucl Med 2005; 46:128S-140S Non-Hodgkin's lymphoma (NHL) is expected to be newly ...
|
|
Radioimmunotherapy of Non-Hodgkin's Lymphoma with ^sup 90^Y-DOTA Humanized Anti-CD22 IgG (^sup 90^Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?
The Journal of Nuclear Medicine; 12/1/2003; Sharkey, Robert M; Brenner, Arnold; Burton, Jack; Hajjar, George; Et al; 11793 words;
... studied in patients with non-Hodgkin's lymphoma (NHL) to assess biodistribution ... Words: radioimmunotherapy; non-Hodgkin's lymphoma; anti-CD22; ^sup 90^Y-epratuzumab ... advances in the treatment of non-Hodgkin's lymphoma (NHL), culminating ...
|
|
Therapeutic Potential of ^sup 90^Y- and ^sup 131^I-Labeled Anti-CD20 Monoclonal Antibody in Treating Non-Hodgkin's Lymphoma with Pulmonary Involvement: A Monte Carlo-Based Dosimetric Analysis
The Journal of Nuclear Medicine; 1/1/2007; Song, Hong; Du, Yong; Sgouros, George; Prideaux, Andrew; Et al; 5325 words;
... common in patients with non-Hodgkin's lymphoma (NHL). ^sup 90^Y- and ^sup ... lung metastases. Key Words: non-Hodgkin's lymphoma; pulmonary metastases; dosimetry ... involvement is common in non-Hodgkin's lymphoma (NHL). Pulmonary involvement ...
|
|
POTPOURRI: Non-Hodgkin's lymphoma rising
Filipino Reporter; 4/12/2001; Sibal, Meg; 1095 words;
... Reporter 04-12-2001 POTPOURRI: Non-Hodgkin's lymphoma rising SINCE our last column on non-Hodgkin's lymphoma (FR, 9/13-19/94), not too long ... rising number of AIDS patients. Non-Hodgkin's lymphoma is a cancer of the lymphatic system ...
|
|
Anemia of cancer in intermediate-grade non-Hodgkin's lymphoma.
Southern Medical Journal; 8/1/2002; Morrow, Thomas J. Volpe, Salvatore Gupta, Sanjay Tannous, Rima E. Fridman, Moshe; 5943 words;
... with intermediate-grade non-Hodgkin's lymphoma (IGNHL) treated in a community-bas ... to 1994 or 1995 to 1999. Non-hodgkin's lymphoma was categorized as limited ... significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol 1998 ...
|
|
Primary gastrointestinal non Hodgkin's lymphoma chemotherapy alone an effective treatment modality: Experience from a single centre in India
Indian Journal of Cancer; 1/1/2006; Raina, Vinod; Sharma, Atul; Vora, Amish; Shukla, N; Deo, SVS; Dawar, R; 2863 words;
Introduction The incidence of non-Hodgkin's lymphoma (NHL) has been increasing ... 1. Devassa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States ... prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 1991;27:1201 ...
|
|
Non-Hodgkin's lymphoma facts
The Pantagraph Bloomington, IL; 5/28/2007; 411 words;
Non-Hodgkin's lymphoma facts- Non-Hodgkin's lymphoma is a cancer that begins in the lymphatic system, which ... spleen, thymus, stomach, skin and small intestine.- Non-Hodgkin's lymphoma begins when a lymphocyte (a B cell or T cell) becomes ...
|
|
Pesticide Exposure and Non-Hodgkin's Lymphoma.(Statistical Data Included)
American Family Physician; 8/1/1999; 358 words;
The incidence of non-Hodgkin's lymphoma is increasing in many countries ... with an increased risk for non-Hodgkin's lymphoma; however, few studies to date ... with an increased risk for non-Hodgkin's lymphoma. Hardell and Eriksson assessed ...
|
|
Dosimetry and Radioimmunotherapy of Non-Hodgkin's Lymphoma/REPLY
The Journal of Nuclear Medicine; 12/1/2004; Postema, Ernst J; Britton, Keith E; 1217 words;
... raclioimmunotherapy (RlT) of non-Hodgkin's lymphoma (NHL) (1). In brief, he ... KE. Radioimmunothcrapy of non-Hodgkin's lymphoma [letlerl. J Nucl Med. 2004 ... Radioimmunothcrapy of B-cell non-Hodgkin's lymphoma. Eur J Nucl Med. 2001; 28 ...
|
|
Techniques for using Bexxar for the treatment of non-Hodgkin's lymphoma
Journal of Nuclear Medicine Technology; 9/1/2002; Seldin, David W; 2634 words;
... Bexxar for the Treatment of Non-Hodgkin's Lymphoma* Objective: This article ... radioimmunotherapy and treatment of non-Hodgkin's lymphoma by a new radiopharmaceutical ... explain why treatment of non-Hodgkin's lymphoma is enhanced by this ...
|
|
Prognostic role of natural killer cells in pediatric non-Hodgkin's lymphomas
Turkish Journal of Cancer; 4/1/2003; Aktas, Safiye; Ortaç, Ragip; Diniz, Gülden; Erbay, Ayse; Vergin, Canan; 2571 words;
... prognostic significance in non-Hodgkin's lymphoma has yet to be determined. Fifty-seven pediatric non-Hodgkin's lymphoma patients (containing noncleaved ... 33(2):91-95] KEY WORDS: Non-Hodgkin's lymphoma, CD57, NK cell, prognosis ...
|
|
(90)Y-DOTA-hLL2: An agent for radioimmunotherapy of non-Hodgkin's lymphoma
The Journal of Nuclear Medicine; 1/1/2003; Griffiths, Gary L; Govindan, Serengulam V; Sharkey, Robert M; Fisher, Darrell R; Goldenberg, David M; 1880 words;
... further development against non-Hodgkin's lymphoma. We sought to establish ... for radioimmunotherapy of non-- Hodgkin's lymphoma, with an in vivo model demonstrating ... follicular, or transformed B-cell non-Hodgkin's lymphoma. Crit Rev Oncol ...
|
|
Administration guideliens for radioimmunotherapy of non-hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody
The Journal of Nuclear Medicine; 2/1/2002; Wagner, Henry N Jr; Wiseman, Gregory A; Marcus, Carol S; Nabi, Hani A; Et al; 1192 words;
... follicular, or CD20+ transformed non-Hodgkin's lymphoma (NHL). ^sup 90^Y-ibritumomab ... Words: radioimmunotherapy; non-Hodgkin's lymphoma; ^sup 90^Y-ibritumomab tiuxetan ... rituximab-refractory follicular non-Hodgkin's Lymphoma [abstract] ... .
|
See all results from premium newspaper and magazine articles, images, maps and more at HighBeam Research.
Related articles from newspapers, magazines and other sources:
Primary non-Hodgkin's lymphoma of the frontal sinus: case report and review of the literature.
Ear, Nose and Throat Journal; 1/1/2005; Neves, Maura C. Lessa, Marcus M. Voegels, Richard L. Butugan, Ossamu; 2833 words;
|
Adipose tissue levels of organochlorine pesticides and polychlorinated biphenyls and risk of non-Hodgkin's lymphoma.(Research / Article)
Environmental Health Perspectives; 6/1/2004; Quintana, Penelope J.E. Delfino, Ralph J. Korrick, Susan Ziogas, Argyrios Kutz, Frederick W. Jones, Ellen L. Laden, Francine Garshick, Eric; 9424 words;
|
Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: [beta]-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. (Research).
Environmental Health Perspectives; 2/1/2003; Cantor, Kenneth P. Strickland, Paul T. Brock, John W. Bush, David Helzlsouer, Kathy Needham, Larry L. Zahm, Shelia Hoar Comstock, George W. Rothman, Nathaniel; 5349 words;
|
A Case-Control Study of Nitrate in Drinking Water and Non-Hodgkin's Lymphoma in Minnesota.
Archives of Environmental Health; 9/1/2000; FREEDMAN, D. MICHAL CANTOR, KENNETH P. WARD, MARY H. HELZLSOUER, KATHY J.; 2818 words;
|
Childhood primary parotid non-Hodgkin's lymphoma with direct intracranial extension: a case report.
Ear, Nose and Throat Journal; 12/1/2004; Hafner, Jonathan W. Costello, Thomas H. Stocks, Rose Mary S. Ibrahim, Fadi Thompson, Jerome W.; 1996 words;
|
Primary non-Hodgkin's lymphoma of the frontal sinus: How we diagnosed it.
Ear, Nose and Throat Journal; 9/1/2000; El-Hakim, Hamdy Ahsan, Farhan Wills, Leslie C.; 1718 words;
|
Leukemia and non-Hodgkin's lymphoma and residential proximity to industrial plants.
Archives of Environmental Health; 3/1/1991; Linos, Athena Blair, Aaron Gibson, Robert W. Everett, George Van Lier, Stephanie Cantor, Kenneth P. Schuman, Leonard Burmeister, Leon; 2139 words;
|
Systemic non-Hodgkin's lymphoma in persons with HIV infection.
Research Initiative/Treatment Action!; 9/1/2000; Vilchez, Regis Butel, Janet S.; 2169 words;
|
Red meat & lymphoma. (risk factor for non-Hodgkin's lymphoma may be amount of red meat consumed according to research by the University of Iowa)(Brief Article)
Nutrition Action Healthletter; 10/1/1996; Liebman, Bonnie; 154 words;
|
Rituximab with or without pixantrone in treating patients with indolent non-Hodgkin's lymphoma. (Clinical Trial Review).
Journal of Drugs in Dermatology; 8/1/2003; 537 words;
|
|
|